PT2917209T - Derivados de 1-[1-(benzoil)-pirrolidina-2-carbonil]pirrolidina-2-carbonitrilo - Google Patents

Derivados de 1-[1-(benzoil)-pirrolidina-2-carbonil]pirrolidina-2-carbonitrilo

Info

Publication number
PT2917209T
PT2917209T PT137948378T PT13794837T PT2917209T PT 2917209 T PT2917209 T PT 2917209T PT 137948378 T PT137948378 T PT 137948378T PT 13794837 T PT13794837 T PT 13794837T PT 2917209 T PT2917209 T PT 2917209T
Authority
PT
Portugal
Prior art keywords
carbonethyl
pyrolidine
pyrrolidine
benzoyl
carbonyl
Prior art date
Application number
PT137948378T
Other languages
English (en)
Portuguese (pt)
Inventor
Giralt Lledó Ernest
Tarragó Clua Teresa
Prades Cosano Roger
Royo Gracia Soledad
Original Assignee
Univ Barcelona
Fundació Inst De Recerca Biomèdica (Irb Barcelona)
Iproteos S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Barcelona, Fundació Inst De Recerca Biomèdica (Irb Barcelona), Iproteos S L filed Critical Univ Barcelona
Publication of PT2917209T publication Critical patent/PT2917209T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epidemiology (AREA)
PT137948378T 2012-11-12 2013-11-11 Derivados de 1-[1-(benzoil)-pirrolidina-2-carbonil]pirrolidina-2-carbonitrilo PT2917209T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12382446.8A EP2730571A1 (en) 2012-11-12 2012-11-12 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives

Publications (1)

Publication Number Publication Date
PT2917209T true PT2917209T (pt) 2017-03-31

Family

ID=47278735

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137948378T PT2917209T (pt) 2012-11-12 2013-11-11 Derivados de 1-[1-(benzoil)-pirrolidina-2-carbonil]pirrolidina-2-carbonitrilo

Country Status (25)

Country Link
US (2) US10125097B2 (https=)
EP (2) EP2730571A1 (https=)
JP (1) JP6203278B2 (https=)
KR (1) KR102151290B1 (https=)
CN (1) CN104903314B (https=)
AU (1) AU2013343430B2 (https=)
BR (1) BR112015010377A8 (https=)
CA (1) CA2890042C (https=)
CY (1) CY1118818T1 (https=)
DK (1) DK2917209T3 (https=)
EA (1) EA028422B1 (https=)
ES (1) ES2621672T3 (https=)
HR (1) HRP20170485T1 (https=)
HU (1) HUE032472T2 (https=)
LT (1) LT2917209T (https=)
ME (1) ME02706B (https=)
MX (1) MX367488B (https=)
NZ (1) NZ709096A (https=)
PL (1) PL2917209T3 (https=)
PT (1) PT2917209T (https=)
RS (1) RS55865B1 (https=)
SI (1) SI2917209T1 (https=)
SM (1) SMT201700202T1 (https=)
WO (1) WO2014072498A1 (https=)
ZA (1) ZA201504269B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2730571A1 (en) 2012-11-12 2014-05-14 Universitat De Barcelona 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
EP3031458A1 (en) * 2014-12-09 2016-06-15 Iproteos S.L. Use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole in the treatment of schizophrenia-associated cognitive deficits
JP2021506972A (ja) 2017-12-15 2021-02-22 プラクシス バイオテック エルエルシー 線維芽細胞活性化タンパク質の阻害剤
CN113811529A (zh) 2018-12-21 2021-12-17 普拉西斯生物技术有限责任公司 成纤维细胞激活蛋白抑制剂
BR112023000335A2 (pt) * 2020-07-07 2023-01-31 Accure Therapeutics S L 1-[1-(4-benzilóxi-3,5-diflúor-benzoil)-4-flúor-pirrolidina-2-carbonil]-pirrolidina-2-carbonitrila
MY208099A (en) 2020-12-28 2025-04-15 Sarawak Biodiversity Council Compound for treating neurodegenerative diseases and its isolation method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018891A1 (en) * 1990-06-04 1991-12-12 Pfizer Inc. Aromatic pyrrolidine and thiazolidine amides
US6159938A (en) 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
HUT76640A (en) * 1995-08-17 1997-10-28 Chinoin Gyogyszer Es Vegyeszet Compounds of pharmaceutical activity cyclic amide derivatives, pharmaceutical compositions containing them, process for producing them and their use
DE19603510A1 (de) 1996-02-01 1997-08-07 Knoell Hans Forschung Ev Die Verwendung von Terrecyclolsäure A und Terrecyclolsäure A-Derivate als neue Inhibitoren der humanen Prolyl-Oligopeptidase
MXPA03000223A (es) * 2000-07-19 2003-06-06 Hoffmann La Roche Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina.
FI20011466A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö
FI20030014A0 (fi) 2003-01-03 2003-01-03 Orion Corp Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä
FI20031018A0 (fi) 2003-07-04 2003-07-04 Orion Corp Parannus aivovammasta toipumiseen
JP4630192B2 (ja) 2003-09-24 2011-02-09 日本化薬株式会社 プロリルオリゴペプチダーゼ阻害剤
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors
ES2302473B1 (es) 2006-12-22 2009-06-12 Universidad De Barcelona Agente terapeutico para el tratamiento del desorden afectivo bipolar en mamiferos.
WO2010083570A1 (en) * 2009-01-23 2010-07-29 The University Of Sydney Novel metabolic disease therapy
EP2730571A1 (en) 2012-11-12 2014-05-14 Universitat De Barcelona 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives

Also Published As

Publication number Publication date
US10611727B2 (en) 2020-04-07
CN104903314B (zh) 2018-06-05
CA2890042C (en) 2021-06-01
DK2917209T3 (en) 2017-04-18
CN104903314A (zh) 2015-09-09
US20190084927A1 (en) 2019-03-21
SI2917209T1 (sl) 2017-05-31
CY1118818T1 (el) 2018-01-10
LT2917209T (lt) 2017-04-25
HK1214597A1 (en) 2016-07-29
JP6203278B2 (ja) 2017-09-27
EA201590942A1 (ru) 2015-10-30
MX2015005931A (es) 2016-02-05
ME02706B (me) 2017-10-20
EP2917209B1 (en) 2017-02-08
MX367488B (es) 2019-08-20
AU2013343430B2 (en) 2017-05-25
WO2014072498A1 (en) 2014-05-15
ZA201504269B (en) 2016-09-28
US20160168088A1 (en) 2016-06-16
AU2013343430A1 (en) 2015-07-02
BR112015010377A2 (pt) 2017-07-11
PL2917209T3 (pl) 2017-09-29
EP2917209A1 (en) 2015-09-16
SMT201700202T1 (it) 2017-05-08
EP2730571A1 (en) 2014-05-14
NZ709096A (en) 2018-04-27
HUE032472T2 (en) 2017-10-30
US10125097B2 (en) 2018-11-13
EA028422B1 (ru) 2017-11-30
HRP20170485T1 (hr) 2017-06-02
CA2890042A1 (en) 2014-05-15
KR20150082634A (ko) 2015-07-15
JP2015536965A (ja) 2015-12-24
ES2621672T3 (es) 2017-07-04
KR102151290B1 (ko) 2020-09-03
RS55865B1 (sr) 2017-08-31
BR112015010377A8 (pt) 2018-01-16

Similar Documents

Publication Publication Date Title
CY2022027I2 (el) Παραγωγα βενζιμιδαζολο-προλινης
EP2876105A4 (en) 1- (CYCLOALKYL-CARBONYL) PROLIN DERIVATIVE
HRP20181429T1 (hr) Novi derivati benzimidazola kao inhibitori kinaze
ITMI20131102A1 (it) Gestione harq-ack per subframe di dowlink non intenzionali
CL2014002533A1 (es) N-ciclilamidas como nematicidas
EP2936418A4 (en) FPGA MEMORY PAGING
LT2841428T (lt) Dnr-pk inhibitoriai
PT2878018T (pt) Resumo
EP2896914A4 (en) ACCUMULATOR
SMT201600114B (it) Inibitori di beta-secretasi
EP2884134A4 (en) HEAT REGULATORS
DK2836160T3 (da) Visceral debranching-stentgraft
PT2674413T (pt) Resumo
DK2758523T3 (da) Stromastamceller
PT2831109T (pt) Resumo
PT2825212T (pt) Resumo
EP2829738A4 (en) ACCUMULATOR
EP2888965A4 (en) KIMONO
EP2860406A4 (en) ACCUMULATOR
CO6801714A2 (es) 1-(heterociclico carbonil)-pirrolidinas 2-sustituidas
EP2847201A4 (en) 6-oxo-purin-phosphoribosyl INHIBITORS
CO6781473A2 (es) 1-(heterociclo carbonil) piperidinas
EP2865898A4 (en) ACCUMULATOR
PT2917209T (pt) Derivados de 1-[1-(benzoil)-pirrolidina-2-carbonil]pirrolidina-2-carbonitrilo
EP2839273A4 (en) MULTILAYER GEL